Variant report
Variant | esv3326932 |
---|---|
Chromosome Location | chr8:34613510-34617008 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145698080 | chr8:34613519-34613520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538694694 | chr8:34613537-34613538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115690261 | chr8:34613542-34613543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73671543 | chr8:34613634-34613635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147738933 | chr8:34613671-34613672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555294216 | chr8:34613704-34613705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11988462 | chr8:34613739-34613740 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs544331629 | chr8:34613751-34613752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556145435 | chr8:34613756-34613757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577707269 | chr8:34613761-34613762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188985367 | chr8:34613775-34613776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560820432 | chr8:34613807-34613808 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111589879 | chr8:34613854-34613855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551096262 | chr8:34613908-34613909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527999601 | chr8:34613955-34613956 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs16882913 | chr8:34613967-34613968 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs73671544 | chr8:34613977-34613978 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs531648930 | chr8:34613984-34613985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75109459 | chr8:34614047-34614048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569399249 | chr8:34614107-34614108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571448612 | chr8:34614132-34614133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532355833 | chr8:34614151-34614152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142583032 | chr8:34614202-34614203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566729744 | chr8:34614236-34614237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533857715 | chr8:34614283-34614284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555495388 | chr8:34614305-34614306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567349795 | chr8:34614367-34614368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181065735 | chr8:34614368-34614369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146743372 | chr8:34614380-34614381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs151289326 | chr8:34614444-34614445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544994673 | chr8:34614469-34614470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536797346 | chr8:34614472-34614473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186213022 | chr8:34614482-34614483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572660195 | chr8:34614504-34614505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150315050 | chr8:34614556-34614557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1403377 | chr8:34614570-34614571 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs531780170 | chr8:34614640-34614641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543642287 | chr8:34614655-34614656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79274617 | chr8:34614670-34614671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568349069 | chr8:34614672-34614673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs1522854 | chr8:34614675-34614676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376835447 | chr8:34614676-34614677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1522853 | chr8:34614677-34614678 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs200470685 | chr8:34614679-34614680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565948101 | chr8:34614746-34614747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189452043 | chr8:34614775-34614776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572661591 | chr8:34614804-34614805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549000617 | chr8:34614844-34614845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567604056 | chr8:34614872-34614873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538018817 | chr8:34614920-34614921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 21806811 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bladder cancer | 19088036 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 20459607 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Neuroticism | 17667963 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 17001308 | CNVD |
Breast cancer | 17157792 | CNVD |
Cancer | 17001308 | CNVD |
Cancer | 18840272 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Breast cancer | 21328542 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Intellectual disability | 22045946 | CNVD |
Lung cancer | 17925434 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21364760 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:34611000-34614400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr8:34613200-34615400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr8:34613800-34614000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr8:34614400-34614600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |